If you love STAT, it's a good week to subscribe. We just launched a new paywall. Readers get 3 'free' stories. STAT+ exclusives will remain subscriber-only.

Best deal: $30 for 3 mos. Support high-quality journalism, which isn't cheap to produce! statnews.com

Huge congratulations to Casey Ross Bob Herman for winning the coveted 2024 NIHCM Award for Investigative and General Reporting for their eye-opening series, 'Denied by AI: Consequences for Sick and Vulnerable Americans.''

The day-to-day economics of fighting infectious diseases are tough, as Vir Biotechnology's repositioning of development priorities shows. Terrific piece by my colleague Jason Mast.
🔒
statnews.com/2024/04/15/vir…

It *seems* like the #H5N1 viruses rampaging through the Americas have evolved to be better adapted to infecting wild birds & less adept at infecting people. But leading flu virologist Ron Fouchier is not assuaged. My conversation with him. statnews.com/2024/04/05/bir…

the first story from STAT's inaugural disability reporting fellow Timmy Broderick is here! read it! on how few people who are eligible for cochlear implants actually get them, and on how access is even worse for certain marginalized populations: statnews.com/2024/04/04/coc…

Amylyx Pharmaceuticals will take its ALS drug off the market in the U.S. and Canada, ending a multi-year saga for patients with the disease. trib.al/5dAA6y2

What we know about H5N1 bird flu in cows — and the risk to humans. Via Helen Branswell 🇨🇦 statnews.com/2024/04/03/h5n…

Why the world’s most expensive drug might not be all that overpriced

In which I shill for the makers of some multi million dollar medicines

statnews.com/2024/03/28/gen…

The #Covid19 pandemic was awful. But it gave people who study immune responses an opportunity to see things scientists have never before witnessed in real time and at a global scale. A number told me about what was an extraordinary opportunity. statnews.com/2024/03/28/cov…

BREAKING: Supreme Court mifepristone arguments focus on physicians’ right to sue, not FDA judgment statnews.com/2024/03/26/sup… via STAT Sarah Owermohle

Gene-edited pig kidney transplanted into a living patient for the first time statnews.com/2024/03/21/fir… via STAT

Happening today!

The most expensive drug in history was approved this week. It’s already transformed dozens of children’s lives

And it could save hundreds more — if doctors can find the kids, that is, and if insurers are willing to pay for it.

W/Megan Molteni
statnews.com/2024/03/20/gen…

PBMs love Humira because of the big rebates that come with it. They don't really like Humira biosimilars because those drugs don't come with much, if any, rebates. So, CVS Caremark came up with a way to protect that profit: by creating a 'rebate credit.' statnews.com/2024/03/18/hum…

It's one of my fav times of the year...Applications are now open for the Sharon Begley Science Reporting Fellowship at STAT.

If you're an early-career reporter of color who's curious about the world of science journalism, apply!

statnews.com/careers/sharon…

We're very excited about this. STAT subscribers can sign up here: statnews.com/signup/scoreca…

Gene therapies for hemophilia have arrived, after decades of work. And yet, few patients seem interested

Really sharp Jason Mast STAT story on why, and what it could mean for other gene therapies

statnews.com/2024/03/13/hem…

Part 2 of 'War on Recovery'' investigation: Searing stories of how rigid rules at methadone clinics are jeopardizing patients’ path to recovery from opioid addiction statnews.com/2024/03/12/met… via STAT

In December, Fresenius sold National Cardiovascular Partners, which operates cardiac cath labs across the country, to an unnamed buyer. Turns out that buyer was UnitedHealth Group. $UNH quietly bought dozens of outpatient centers like this last year. statnews.com/2024/03/11/uni…

In a surprise move, the FDA has called for a meeting of outside advisers to discuss whether an Alzheimer’s drug from Eli Lilly should be approved. trib.al/4v7CG4b